{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:21:46Z","timestamp":1777537306514,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Bill & Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery\/Comprehensive Antibody Vaccine Immune Monitoring Consortium"},{"name":"Collaboration for AIDS Vaccine Discovery\/Vaccine Immunology Statistical Center"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH\/NIAID Reagent Resource Support Program for AIDS Vaccine Development, Quality Biological, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jim.2011.09.007","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T13:51:16Z","timestamp":1316785876000},"page":"57-67","source":"Crossref","is-referenced-by-count":80,"title":["Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells"],"prefix":"10.1016","volume":"375","author":[{"given":"Christopher A.","family":"Todd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelli M.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunda","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blake","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Patricia","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Sarzotti-Kelsoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2011.09.007_bb0015","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bbrc.2006.07.163","article-title":"Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration","volume":"348","author":"Choudhry","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.jim.2011.09.007_bb0005","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1371\/journal.pmed.0020025","article-title":"The Global HIV\/AIDS Vaccine Enterprise: scientific strategic plan","volume":"2","author":"Coordinating Committee of the Global HIV\/AIDS Vaccine Enterprise","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.jim.2011.09.007_bb0020","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/516443","article-title":"Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. AIDS Clinical Trials Group Antibody Selection Working Group","volume":"175","author":"D'Souza","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2011.09.007_bb0025","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1128\/JVI.74.18.8358-8367.2000","article-title":"Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120","volume":"74","author":"Derdeyn","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2011.09.007_bb0030","doi-asserted-by":"crossref","first-page":"e4505","DOI":"10.1371\/journal.pone.0004505","article-title":"International network for comparison of HIV neutralization assays: the NeutNet report","volume":"4","author":"Fenyo","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2011.09.007_bb0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/aid.2009.0186","article-title":"Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production","volume":"26","author":"Geonnotti","year":"2010","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jim.2011.09.007_bb0040","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"Li","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2011.09.007_bb0045","doi-asserted-by":"crossref","first-page":"11776","DOI":"10.1128\/JVI.01730-06","article-title":"Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa","volume":"80","author":"Li","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2011.09.007_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1211s64","article-title":"Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays","author":"Montefiori","year":"2005","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.jim.2011.09.007_bb0060","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1","volume":"72","author":"Platt","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2011.09.007_bb0065","first-page":"277","article-title":"Establishment of a national network of validated and qualified laboratories for neutralizing anti-vaccinia antibodies titration","volume":"33","author":"Poirier","year":"2005","journal-title":"Biol. J. Int. Assoc. Biol. Stand."},{"key":"10.1016\/j.jim.2011.09.007_bb0070","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2011.09.007_bb0075","doi-asserted-by":"crossref","first-page":"e1000067","DOI":"10.1371\/journal.pmed.1000067","article-title":"Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials","volume":"6","author":"Sarzotti-Kelsoe","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.jim.2011.09.007_bb0080","doi-asserted-by":"crossref","first-page":"12585","DOI":"10.1128\/JVI.01726-08","article-title":"Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research","volume":"82","author":"Takeuchi","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2011.09.007_bb0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nm0910-981","article-title":"The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise","volume":"16","author":"The Council of the Global HIV Vaccine Enterprise","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jim.2011.09.007_bb0085","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jim.2011.09.007_bb0090","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175911002523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175911002523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T16:40:05Z","timestamp":1593016805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175911002523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":17,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0022175911002523"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2011.09.007","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}